Lina Feng

Pharmacophore-Based Virtual Screening and Experimental Validation of Novel Inhibitors against Cyanobacterial Fructose-1, 6-/Sedoheptulose-1, 7-bisphosphatase

Di Wu, Rui Zhang, Yao Sun, 2014, J. Chem. Inf. Model..

Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways.

Lina Feng, Xiaojuan Du, Lei Zhang, 2020, International immunopharmacology.

Pdcd4 promotes lipid deposition by attenuating PPARα-mediated fatty acid oxidation in hepatocytes

Lina Feng, Xiaojuan Du, Shemin Lu, 2022, Molecular and Cellular Endocrinology.

Cholesterol-induced leucine aminopeptidase 3 (LAP3) upregulation inhibits cell autophagy in pathogenesis of NAFLD

Lina Feng, Xiaojuan Du, Shemin Lu, 2022, Aging.

Epigallocatechin Gallate Protects Mice against Methionine–Choline-Deficient-Diet-Induced Nonalcoholic Steatohepatitis by Improving Gut Microbiota To Attenuate Hepatic Injury and Regulate Metabolism

Lina Feng, Xiaojuan Du, Chunyan Yin, 2020, ACS omega.

Long Noncoding RNA lnc-HC Regulates PPARγ-Mediated Hepatic Lipid Metabolism through miR-130b-3p

Lina Feng, Mengyao Sun, Xiaojuan Du, 2019, Molecular therapy. Nucleic acids.

Inhibition of miR‐188‐5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway

Lina Feng, Xiaojuan Du, Yimeng Zhou, 2021, Journal of cellular and molecular medicine.

LNCHC directly binds and regulates YBX1 stability to ameliorate metabolic dysfunction-associated steatotic liver disease progression.

Lina Feng, Kaikai Lu, Qian Chen, 2024, Liver international : official journal of the International Association for the Study of the Liver.